Braeburn Pharmaceuticals

Opioid dependence is a chronic relapsing neurological disorder that impacts areas of the brain that are critical to judgment, decision-making, learning, memory and behavior control. With very few medications available, Access Health is proud to bring you news of a novel approach to treatment. Recognizing the need for innovative approaches to addiction treatment as a chronic relapsing disease, Braeburn Pharmaceuticals is bringing a new treatment in the form of an implant for opioid dependence. Join us.